{"id":28366,"date":"2020-11-05T12:56:48","date_gmt":"2020-11-05T12:56:48","guid":{"rendered":"https:\/\/conectas.org\/noticias\/the-paths-to-universal-access-to-the-covid-19-vaccine\/"},"modified":"2021-04-01T12:52:47","modified_gmt":"2021-04-01T12:52:47","slug":"the-paths-to-universal-access-to-the-covid-19-vaccine","status":"publish","type":"noticia","link":"https:\/\/conectas.org\/en\/noticias\/the-paths-to-universal-access-to-the-covid-19-vaccine\/","title":"The paths to universal access to the Covid-19 vaccine","content":"

\"\"<\/p>\n

In September, the federal government announced an investment of R$2.5 billion for Brazil to join the Covax Facility \u2013 a coalition of 165 countries that plans to guarantee universal access to the vaccine against the novel coronavirus. The agreement gives the country access to at least nine vaccines being developed around the world.<\/span><\/p>\n

The eighth issue of the Rights in the Pandemic Bulletin provides an analysis of the possible paths for countries in the pursuit of universal immunization against Covid-19, such as Covax, and addresses issues that have not yet been clarified about these agreements.<\/span><\/p>\n

\u201cWhatever the \u2018strategy\u2019 to be adopted, international cooperation is still the only truly global solution to this pandemic and the most promising way to ensure that people in all corners of the world have access to vaccines as soon as they become available, regardless of their wealth or geopolitical position,\u201d explained Fernando Aith, a researcher at Cepedisa (Center for Studies and Research on Health Law) of the University of S\u00e3o Paulo, who contributed to this issue.\u00a0<\/span><\/p>\n

The Bulletin is part of the project \u201cMapping and analysis of the legal norms for responding to Covid-19 in Brazil\u201d, a partnership between\u00a0<\/span>Cepedisa<\/span>\u00a0<\/b><\/a>and Conectas.\u00a0<\/span><\/p>\n